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Data derived from molecular microbiological investigations of the human vagina have led to the discovery of resident bacterial
communities that exhibit marked diﬀerences in terms of species composition. All undergo dynamic changes that are likely due to
intrinsic host and behavioral factors. Similar types of bacteria have been found in both amniotic ﬂuid and the vagina, suggesting
a potential route of colonization. Given that not all of the species involved in intrauterine infections are readily cultivated, it is
important that culture-independent methods of analysis must be used to understand the etiology of these infections. Further
research is needed to establish whether an ascending pathway from the vagina to the amniotic cavity enables the development of
intrauterine infections.
1.Introduction
Preterm birth is the leading cause of neonatal mortality
worldwide [1], yet the underlying etiologies remain largely
unknown.Despitetheimplementationofmanypublichealth
measuresandmedicalinterventions,pretermbirthscontinue
toincrease(Figure1).Astrongbodyofevidencesuggeststhat
intrauterine infection is animportant mechanism thatmight
account for 25–40% of preterm births [2, 3]. However, this
is probably a conservative estimate because many infections
are likely to be subclinical, and the pathogens responsible for
these infections may be diﬃcult to detect with conventional
culture techniques [4, 5]. Furthermore, our current under-
standing of normal vaginal microbiota, bacterial vaginosis,
and the relationship to intrauterine infection and preterm
birth is limited and incomplete.
Eﬀorts to understand the microbiology of the human
vagina have been hampered in the past by the use of
cultivation-based approaches that have signiﬁcant limita-
tions, and because longitudinal studies on the dynamics of
vaginal bacterial communities have been lacking. Current
eﬀorts to understand the human microbiome and its role in
preventing infections have entered the metagenomic era in
which high throughput DNA sequencing technologies are
used to characterize the diversity and function of microbial
communities. Not only does this dramatically change the
types of data routinely obtained from clinical samples [6],
but it provides greater insight to microbial community
structure, function, dynamics, and the interspecies
interactions that are central to explaining how the human
microbiota functions to maintain host health or predispose
individuals to diseases [7–9]. We argue that in addition to
the technical advances that these methodologies oﬀer we
need conceptual advances in the way these data are analyzed,
interpreted, and translated into clinical practice. Through
theseadvancesourunderstandingofinfectiousprocessesand
strategies to prevent and treat infections can be improved.
2. The Value of 16S rRNA Gene
Sequence AnalysesinStudiesof
the Human Microbiome
Our understanding of the composition of microbial com-
munities associated with humans has been largely derived2 Infectious Diseases in Obstetrics and Gynecology
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Figure 1: Percentage of all births classiﬁed as preterm in the USA,
1981–2004 (Source: Goldenberg et al. [16])
from studies that required the cultivation of microbial
populations. Hence, our current understanding of microbe-
host interactions is limited because the majority of microbial
species resist cultivation in the laboratory [10]. Unques-
tionably, the cultivation of microorganisms is essential to
fully understand the physiology and phenotypic properties
of organisms, and thus invaluable to clinical microbiology.
However, expansive studies done to assess inter- and intra-
personal variation in microbial community composition or
to explore ecological relationships and answer epidemiologi-
calquestionsrequiremethodsthatprovidedetailed,in-depth
information about microbial diversity while being cost-
eﬀective and amenable to high throughput sample analysis.
In recent years, investigators have begun to rely on culture-
independent methods based on analysis of 16S rRNA gene
sequences to expand our knowledge of microbial diversity.
These methods circumvent the need to cultivate organisms
by analyzing nucleic acids directly extracted from samples.
Typically the 16S rRNA genes in samples are ampliﬁed
using primers that anneal to highly conserved regions of
the gene and then amplicons are sequenced. Phylogenetic
analysis of the sequences obtained allows for classiﬁcation
of the phylotypes (e.g., species) present and is a means to
identify the numerically dominant species in communities,
changes in community composition that occur in responses
to treatments, the inﬂuences of habits and practices, and so
on. As a result, this has become the favored approach to
characterizing microbial populations and communities that
reside in or on the human body [11–15].
It has been estimated that one must sample 80% of the
species in the community to adequately assess microbial
community diversity [17]. Thus, to adequately catalog
the majority of microbial taxa in diverse communities, a
large number of clones must be sequenced, which is both
time-consuming and costly. This high “per sample” cost
has historically limited the number of samples that can
be analyzed, which in turn placed severe constraints on
experimental designs. To alleviate this problem, Sogin et al.
[18] pioneered the use of massively parallel DNA sequencing
ofshort,hypervariableregionsof16SrRNAgenestoproduce
detailed surveys of communities that include low abundance
taxa. Using technology originally developed by 454 Life
Sciences [19, 20] and now manufactured and distributed
by Roche Applied Science over 1 million DNA sequence
reads can be generated in a single pyrosequencing run,
and sequence read lengths are approximately 400–500bp.
To simultaneously analyze multiple samples, each sample is
ampliﬁed using primers that include a unique 6-bp sequence
that provides a way to bin sequences during postsequencing
data analysis. Upwards of 250 samples can be analyzed in a
single sequencing run, yielding 4000 sequences per sample.
Bysimplyreducingthenumberofsamplesperrun,thedepth
of coverage can be increased. This technology circumvents
traditional approaches that require cloning, which allows
users to avoid biases associated with library construction.
Moreover, the novel sequencing chemistry permits the
sequencing of regions of DNA that have secondary structure
or unusual base composition. The lower cost and higher
throughput of such technology when applied to 16S rRNA
gene sequence analysis aﬀords a way to sample microbial
communities at depths that are orders of magnitude greater
than is possible by traditional Sanger sequencing of cloned
16S rRNA amplicons [21].
3. ProﬁlingBacterial Diversityin
the Human Vagina Based on the Analysis of
16S rRNA GeneSequences
3.1. Bacterial Communities in the Human Vagina. In the
past 100 years since the ﬁrst microbiological study of the
human vagina [22], lactobacilli have been thought to be
the predominant members of normal postpubertal vaginal
microﬂora [23]. Studies reliant on the cultivation of organ-
isms have shown that a diverse array of other bacteria such
as Staphylococcus, Ureaplasma, Corynebacterium, Streptococ-
cus,Peptostreptococcus,Gardnerella,Bacteroides,Mycoplasma,
Enterococcus, Escherichia, Veillonella,a n dBiﬁdobacterium,a s
wellastheyeastCandida[24–26]canbepresentbuttypically
in much lower numbers. The species of lactobacilli that have
been cultivated from vaginal samples of healthy women and
identiﬁed based on phenetic characters include Lactobacillus
jensenii, L. acidophilus, L. casei, L. gasseri, L. crispatus, L.
plantarum, L. fermentum, L. cellobiosus, L. brevis, L. minutes,
and L. salivarius [27–29]. Few studies have been done to
assesstemporalvariationinvaginalcommunitycomposition
within individuals, but those completed suggest that these
communities are not subject to dramatic changes in healthy
women, even during menses [30–32].
With advances in DNA sequencing technologies and
decreasedcosts,ourknowledgeofhumanvaginalmicrobiota
has greatly increased in recent years. Several studies have
used culture-independent methods to characterize the vagi-
nal microbial communities of reproductive-age, apparently
healthy and asymptomatic women [33–38]. The analytical
methodologies used and study designs have varied some-
what in terms of sampling diﬀerent regions of the vagina,
diﬀerences in the ethnic backgrounds of women sampled,
the geographical location of populations, sampling times
in relation to the menstrual cycle, and so on. Nonetheless,
these studies are concordant in demonstrating that vaginal
bacterial community composition diﬀers both within andInfectious Diseases in Obstetrics and Gynecology 3
between individuals and several diﬀerent kinds of commu-
nities are known to exist. Thus, a more complicated picture
of vaginal microbiota in healthy, asymptomatic women has
been painted. For example, in a previous study we analyzed
144 vaginal samples from White and Black women, a subset
of those previously collected from more than 3,000 healthy
women across North America [39]. The results showed
that in 80% of the women microorganisms phylogenetically
related to Lactobacillus iners, L. crispatus, L. jensenii,o rL.
gasseri dominated sampled vaginal communities. Overall,
L. iners was the most common species of Lactobacillus in
women of both ethnic groups having been recovered in
66% of the women sampled. L. iners is an underappreciated
member of the normal vaginal biota, as it does not grow
on Rogosa agar that is typically used to isolate lactobacilli.
The remainder of communities had low numbers of lac-
tobacilli, exhibited greater species evenness, and included
high numbers of clones most closely related to Atopobium
and genera of the order Clostridiales, including Megasphaera,
Dialister, Anaerococcus, Finegoldia, Peptostreptococcus,a n d
Eubacterium. In addition, 20–30% of the clones from
these communities were from novel clades in the phylum
Firmicutes. Comparable results were obtained in a recent
studyofhealthy,reproductive-ageJapanesewomen[40].The
ﬁndings of these studies indicate there are a limited number
of diﬀerent kinds of vaginal microbial communities in
asymptomatic, apparently healthy women. Moreover, from
studies of adolescent women (13–15y) [41], it appears that
these communities are established in puberty and may reside
in women until menopause.
Recently, we completed a more detailed and expan-
sive study to characterize vaginal microbiota using high-
throughput methods based on pyrosequencing of barcoded
16S rRNA genes [42]. The subjects were a cohort of 396
North America asymptomatic women equally representing
four ethnic backgrounds (Asian, White, Black, and His-
panic). Women were recruited at three clinical sites: two in
Baltimore at the University of Maryland School of Medicine
and one in Atlanta, at Emory University. The participants
self-identiﬁed their race. All women enrolled in the study
were not pregnant, of reproductive age ranging from 12 to
45 years (mean 30.6 ± 7.32 years), had regular menstrual
cycles (25–35-day menstrual cycles), with a history of sexual
activity, and had not taken any antibiotic or antimycotic
compoundsinthepast30days.Womenwereaskedtorefrain
from sexual activity in the 48h before the visit. The vaginal
swabs were self-collected by women who were not menstru-
ating or using contraceptive devices, such as NuvaRing [42].
In total there were 282 phylotypes identiﬁed in these women.
The communities clustered into ﬁve groups; four of which
were dominated by Lactobacillus iners, L. crispatus, L. gasseri,
or L. jensenii, while the ﬁfth had lower proportions of lactic
acid bacteria and higher proportions of strict and facultative
anaerobes. This low-Lactobacillus group accounted for about
25% of the women sampled. Aside from the diﬀerent
Lactobacillus species, the most abundant taxa identiﬁed in
the human vagina were Prevotella, Megasphaera, Sneathia,
Atopobium, Streptococcus, Dialister, Lachnospira, Anaero-
coccus, Peptoniphilus, Eggerthella, Finegoldia, Rhodobaca,
Anaerotruncus, Ureaplasma, Mycoplasma, Aerococcus, Parvi-
monas, Staphylococcus, Corynebacterium, Veillonella, Gard-
nerella, Gemella,a n dMobiluncus. The most commonly
observed taxa in each community group are shown in
Table 1.Theresultsfurthershowedthathighbacterialspecies
diversitywasobservedinallvaginalcommunities,eventhose
where the phylotype abundance distribution was highly
skewed and dominated by one or a very few phylotypes.
The study cohort consisted of roughly equal numbers of
four ethnicities (white, Asian, black, and Hispanic), and this
oﬀered the opportunity to assess the relationship of ethnic
background on vaginal bacterial community composition.
The proportions of each community group varied among
the four ethnic groups (Figure 2), and these diﬀerences were
statistically signiﬁcant [χ2(10) = 36.8, P<. 0001]. No sta-
tistically signiﬁcant associations were observed between age
andcommunitytypeswithinoracrossethnicgroups.Vaginal
bacterial communities dominated by species of Lactobacillus
(groups I, II, III, and V) were found in 80.2% and 89.7% of
Asian and white women, respectively, but in only 59.6% and
61.9% of Hispanic and black women, respectively. We found
that community group IV was overrepresented in Hispanic
(34.3%) and black (38.9%) women as compared with Asian
(17.6%) and white (9.3%) women. From these data we
conclude that vaginal bacterial communities not dominated
byspeciesofLactobacillusarecommonandappearfrequently
inblackandHispanicwomen.Thedatafromthisstudyarein
accordance with the results of Zhou et al. [37, 39, 40], who
studied the vaginal bacterial communities of white, black,
and Japanese women.
3.2. Temporal Dynamics of Vaginal Bacterial Communities.
Most studies of vaginal microbiology have employed a cross-
sectional study design in which individuals are sampled
at one discrete time point or used an interval-censored
study design such that participant samples are obtained
every few weeks or months [30–32, 43]. As a result little
is known about the temporal dynamics of vaginal bacterial
communities, and many have the mistaken impression that
the composition of these communities is comparatively
invariant over time, except perhaps during menstruation
and following other deliberate disturbances such as sexual
activity or vaginal douching. However, as our understand-
ing of the human microbiome improves, it is becoming
increasinglyapparentthatthebacterialcommunitiesofsome
habitats can markedly change over time and in response to
environmental changes. For example, diﬀerences or changes
in diet can have profound eﬀects on the composition of
bacterial communities of the gastrointestinal tract [44, 45].
To understand how microbial communities in the human
body ﬂuctuate in response to either deﬁned events or
stochastic processes, dynamic community proﬁling studies
are needed [6].
Recently, we completed the sequencing of archived
specimens from a longitudinal study of 33 reproductive age
women who self-collected vaginal swabs every 3 days over
a 16-week time period (see [46], Gajer et al. unpublished).
The vaginal bacterial communities of nearly all women
were dynamic and exhibited marked changes in the relative4 Infectious Diseases in Obstetrics and Gynecology
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Figure 2: Proportions of community groups found in women of diﬀerent ethnic groups (Source: [42]).
abundancesofspeciesovertime.Usuallytheseshiftsinvolved
changes in the relative proportions of species, but in some
cases a distinct turnover in species composition occurred
that persisted over time and was akin to an alternative
equilibrium state. Factors that inﬂuence the dynamics of
communities are currently under investigation, but may
include hormonal ﬂuctuations, sex practices, frequency of
sex, use of vaginal douches, and other feminine hygiene
products, or other factors.
4.The Enigmaof BacterialVaginosis
The risk of preterm birth and low birth weight infants is
markedly increased in women with bacterial vaginosis [47,
48], yet the etiology of bacterial vaginosis remains an enigma
[49]. In simple terms, bacterial vaginosis is said to reﬂect a
disturbed vaginal ecosystem in which Lactobacillus species
arereducedinnumberandthecommunityis“overgrown”by
strictlyanaerobicorganisms[50,51].Clinically,thediagnosis
of bacterial vaginosis requires three of the following four
symptoms or signs [52]: (a) homogeneous, thin, white
discharge that smoothly coats the vaginal walls, (b) presence
of clue cells on microscopic examination, (c) pH of vaginal
ﬂuid >4.5, and (d) a ﬁshy odor of vaginal discharge before
or after addition of 10% KOH. Alternatively, bacterial
vaginosis is diagnosed based on the assessment of bacterial
cellular morphologies observed in samples using criteria
ﬁrst introduced by Spiegel et al. [53] and then modiﬁed by
Nugent et al. [54]. The diagnosis of bacterial vaginosis using
the Nugent criteria is based on a numerical scoring system
(0–10). The score reﬂects the relative abundances of three
kinds of bacterial cell morphotypes in Gram-stained vaginal
smears, namely, large gram-positive rods (Lactobacillus),
small gram-variable rods (G. vaginalis/Bacteroides spp.), and
curved gram-variable rods (Mobiluncus).
The diagnostic criteria used are a critical issue in studies
on the etiology of bacterial vaginosis. While numerous
studies have shown that women with high numbers of Lac-
tobacillus species generally do not have bacterial vaginosis,
it is a logical fallacy to conclude that women whose vaginal
communities have few or no Lactobacillus species have
bacterial vaginosis. Unfortunately, this fallacy is the premise
of the Nugent criteria wherein the degree of “healthiness”
is largely inﬂuenced by scoring the relative abundance of
Lactobacillus species with typical cell morphology. We assert
that while “normal and healthy” can be equated with high
numbers of lactobacilli, the converse—that “unhealthy” can
be equated with low numbers of or no lactobacilli—is not
necessarily true [55]. We postulate that, because of this
logical fallacy, bacterial vaginosis is often over-diagnosed by
Gram’s staining. This could partly account for the reported
high incidence of so-called asymptomatic bacterial vaginosis
in reproductive-age women [56, 57] and could also explain
a proportion of bacterial vaginosis treatment failures and
apparent recurrences of bacterial vaginosis in women [58,
59].
This does not deny the fact that vaginal communities
of women with symptoms of bacterial vaginosis have high
numbers of strictly anaerobic bacteria, many of which
are various taxa that belong to the order Clostridiales.
Several studies have reported this to be the case [60, 61].
We postulate that the presence of these organisms in high
number is necessary but not suﬃcient to elicit the symptoms
associated with bacterial vaginosis, and that diﬀerences
in the complex of symptoms that become manifest are
likely dictated by diﬀerences in the immune response
of a host. This seems sensible given that disease results
not only from the ill eﬀects of microbial activities and
products, but also from the nature and severity of the host
immune response to the organism(s). This is apparent if one
considers that the clinical diagnosis of infection depends
upon the identiﬁcation of the four signs of inﬂammation:
dolor (pain), rubor (redness), calor (heat), and tumor
(swelling) all of which reﬂect host inﬂammatory responses
(http://www.aboutinﬂammation.com/fourclassicsymptoms
oﬁnﬂammation.html).Thus, it is logical to suggest that
when examining the vaginal habitat, clinicians might also
focus on the microbe-host immune system interaction
[62]. Yet, the current diagnosis of asymptomatic bacterial
vaginosis relies only on the microbial component of this
equation and ignores the host component. Thus it seems
unreasonable that the diagnosis of bacterial vaginosis should
be based solely on the absence of certain taxa (lactobacilli)
and presence of others (strict anaerobes). A similar dilemma
occurs in clinical medicine when asymptomatic patients
present with bacteria in their urine. For women, a diagnostic6 Infectious Diseases in Obstetrics and Gynecology
criterion for asymptomatic bacteriuria is two consecutive
midstream clean-catch urine specimens with isolation of the
same species in quantitative counts of at least 100,000CFUs
per mL of urine [63]. And in the case of asymptomatic
bacteruria, there are only a few clinical circumstances
in which antibiotic treatment has been shown to beneﬁt
the patient.
It is important to note in the context of asymptomatic
bacterial vaginosis that studies suggest that women with
low-Lactobacillus dominated microbiota (many of which
would be classiﬁed as asymptomatic bacterial vaginosis) are
at greater risk for adverse outcomes including STD/HIV
infection upon exposure and poor obstetric outcomes
[64, 65].
4.1. Normal Vaginal Microbiota. The results of studies done
using cultivation-independent methods require that we
revise our perceptions of the bacterial species found in
the vaginas of normal and healthy women. As mentioned
above, recent work by Ravel et al. [42] showed that vaginal
bacterial communities could be clustered into ﬁve groups
demonstrating that there is no single core microbiome.
These groups can be readily distinguished on the basis of
two criteria: (a) whether the constituent communities are
dominated by Lactobacillus or not and (b) the particular
species of Lactobacillus present. In the past it has been
claimed that the vaginal bacterial communities of healthy
women are dominated by species of Lactobacillus that
produce hydrogen peroxide [49, 51, 66]. This appears to
be true for some but not all women. The most common
communities are dominated by L. iners, a species that can be
characterized by the inability to produce hydrogen peroxide
[23].Moreover,notonlydoesthisorganismresistcultivation
on commonly used media (which probably accounts for
its absence from most surveys done in the past that relied
on cultivation), but the cell morphology is atypical by
being about 50% smaller (length and width) than the
other species of Lactobacillus common to the human vagina
(Yuan and Forney, unpublished). This could confound the
diagnosisofbacterialvaginosisbasedonNugentcriteria.The
ﬁfth group of vaginal communities found in asymptomatic
womenisheterogeneousintermsofspeciescompositionand
typiﬁed by a dearth of lactobacilli and higher proportions
of strictly anaerobic bacteria including Prevotella, Dial-
ister, Atopobium, Gardnerella, Megasphaera, Peptoniphilus,
Sneathia,Eggerthella,Aerococcus,Finegoldia,andMobiluncus.
A large proportion (27%) of White, Black, Hispanic, and
Asian women in North America have vaginal communities
that cluster within this group, and they are particularly
frequent in Hispanic and Black women (38 and 40%, resp.;
Figure2).Thefactthatthesecommunitiesarenotdominated
by species of Lactobacillus has led some to presume that
these women have bacterial vaginosis [50, 56]. We postulate
that these asymptomatic women with vaginal communities
lacking appreciable numbers of lactobacilli may be misdi-
agnosed as having bacterial vaginosis if Nugent criteria are
used. The fact that these communities appear to reﬂect a
natural state and not disease might account for the high
recurrenceratesandspontaneouscurerateforasymptomatic
bacterialvaginosisthathavebeenobserved[58,59,67,68].If
this is the case, then vaginal bacterial communities that lack
lactobacilli may simply represent another diﬀerence found
among individuals and highlight the importance of person-
alized medicine wherein diﬀerences among individuals are
respected.
There is a widespread discussion over whether asymp-
tomatic gynecologic patients with bacterial vaginosis should
be treated [69] since the risk of therapy must be weighed
against the beneﬁt to patients, and there is increasing
awareness of the need to restrict antibiotic use so as to avoid
selection for antibiotic resistance [70, 71]. The arguments
presented above suggest that the use of antibiotics for the
treatment of asymptomatic bacterial vaginosis might not be
sensible since disturbance of a natural state is the “cure”
one would be attempting to aﬀect. It should be noted that
these communities may tend to revert to their original
state once antibiotic therapy has been completed, and this
could well account for a portion of the so-called treatment
failures that are observed in trials done to assess the
eﬃcacy of antibiotic therapy for curing bacterial vaginosis
[58, 72].
4.2. Treatment of Asymptomatic Bacterial Vaginosis in Preg-
nant Women. Controversy surrounds whether pregnant
women should be screened for the occurrence of asymp-
tomatic bacterial vaginosis and treated with antimicrobial
agents to prevent preterm birth. The basic rationale for
screening and treatment is that bacterial vaginosis is associ-
ated with intra-amniotic infection and therefore is consid-
ered a risk factor for preterm delivery. However, evidence
compiled in the Cochrane Reviews does not support the
concept of widespread screening for bacterial vaginosis
and treatment to prevent premature delivery [73–75]. It is
important to note that a history of a prior preterm birth
is the most signiﬁcant clinical factor in identifying women
with a propensity for preterm labor and delivery [76, 77].
T h eC e n t e r sf o rt h eD i s e a s eC o n t r o l ,a sw e l la sp r o m i n e n t
leaders in the ﬁeld of infectious disease in obstetrics and
gynecology, have recommended that only patients at high
risk for preterm delivery—speciﬁcally only those with a
previous history of a spontaneous preterm birth—should be
treated with antibiotics if they are found to have bacterial
vaginosis [62].
5. Intrauterine Infection and Preterm Birth
Intrauterine infections are a frequent and important mecha-
nism leading to preterm birth. Intrauterine infection begins
in the decidua (uterine lining), extends to the space between
the amnion and chorion, and ﬁnally reaches the amniotic
cavity and fetus [2]. Bacteria have been cultured from the
chorioamnion in 15% of nonlaboring women with intact
membranes who are undergoing caesarean delivery [2].
Likewise, half of all placentas delivered before the end of
the second trimester have been shown to harbor bacteria
in the chorion as detected by culture [78]. The prevalence
of infection is found to be even higher when molecularInfectious Diseases in Obstetrics and Gynecology 7
methods are used to detect bacteria. When ﬂuorescence in-
situ hybridization is done using a DNA probe speciﬁc for
a conserved region of the bacterial 16S rRNA gene, then
bacteria are found in the membranes of up to 70% of
women undergoing elective caesarean section at term [79].
Since these were not cases of preterm birth, these ﬁndings
suggest that the presence of bacteria in the chorioamnion
a l o n ei sn o ta l w a y ss u ﬃcient to cause an inﬂammatory
response that leads to preterm labor and preterm birth.
In contrast, an inﬂammatory response is observed in the
amniotic ﬂuid of more than 80% women in early preterm
labor with intact membranes. Based on these data, it seems
there are two conditions essential for intrauterine infections
to cause preterm birth. First, the infectious organisms must
enter the amniotic cavity and be recognized as foreign by
the host immune system. Second, the bacterial numbers
must breach some threshold to trigger an intra-amniotic
inﬂammatory response, which in turn induces preterm labor
[80].
5.1. Bacterial Species Found in Amniotic Fluid. Ureaplasma
urealyticum, Fusobacterium sp., and Mycoplasma hominis
are the bacterial species most commonly isolated from the
amniotic cavity of women with preterm labor and intact
membranes [81, 82]. Other microorganisms found in the
amniotic ﬂuid include Streptococcus agalactiae, Peptostrep-
tococcus sp., Staphylococcus aureus, Gardenerella vaginalis,
Streptococcus viridians, and Bacteroides sp. Occasionally, Lac-
tobacillus sp., Escherichia coli, Enterococcus faecalis, Neisseria
gonorrhea, and Peptococcus sp., while Haemophilus inﬂuen-
zae, Capnocytophaga sp., Stomatococcus sp., and Clostridium
sp. are rarely recovered [83–85]. More than one microorgan-
ism is isolated from 50% of patients in which the amniotic
cavity is infected [79].
In a recent, very comprehensive analysis, DiGiulio and
colleagues characterized bacterial 16S rRNA gene sequences
in amniotic ﬂuid from women in preterm labor [5]. They
found 18 taxa in the amniotic ﬂuids using molecular
methods of analysis while only 11 taxa were recovered
using culturing methods. In addition, 9 samples were
positive only by PCR ampliﬁcation of 16S rRNA genes,
indicating that false negative results can be obtained by using
only cultivation methods. In this study, Mycoplasma sp.,
Ureaplasma sp., Streptococcus sp., Lactobacillus sp., Prevotella
sp., Delftia sp., Neisseria sp., Fusobacterium sp., Sneathia sp.,
andLeptotrichiasp.werefoundinamnioticﬂuids.Inanother
study by Han et al. [86], twice the numbers of bacterial
taxa were identiﬁed in the amniotic ﬂuids of preterm
delivery patients using cultivation-independent methods as
comparedtocultivation-dependentmethods.Mosttaxawere
similar to those of DiGiulio’s study, but in addition Shigella
sp., Bacteroides sp., Bergeyella sp., and Peptostreptococcus
sp. were observed. While some bacteria in amniotic ﬂuid
have been associated with skin, fecal, and gut microbiota,
most are related to those found in the human vagina. This
suggests a potential connection between the bacterial species
in amniotic ﬂuid with those in the vagina, with the latter
being a potential source of infecting organisms [16] (see
Figure 3).
Ascending
from vagina
Amniocentesis
Retrograde from
abdominal cavity
Haematogeneously
through placenta
Figure 3: Potential routes of intrauterine infection (Source:
Goldenberg et al. [16])
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